● Recruiting

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

Condition: Triple Negative Breast Cancer · Breast Cancer · Endometrial Cancer · Sponsor: Day One Biopharmaceuticals, Inc.

PhasePhase 1/Phase 2

Planned participants360

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

A Study of Emi-Le in Participants with Solid Tumors

This description comes directly from the study's public registry record.

Talk to the study team

Day One Clinical Trials Information · 1-650-484-0899 · clinicaltrials@dayonebio.com

Always discuss trial participation with your own doctor first.

Locations (26)

Mayo Clinic Comprehensive Cancer Center	Phoenix, Arizona, United States	Recruiting
UC Irvine Health-Chao Family Comprehensive Cancer Center	Orange, California, United States	Recruiting
UCSF Helen Diller Family Comprehensive Cancer Center	San Francisco, California, United States	Recruiting
UCLA David Geffen School of Medicine, Division of Hematology/Oncology	Santa Monica, California, United States	Recruiting
Mayo Clinic - Jacksonville	Jacksonville, Florida, United States	Recruiting
Florida Cancer Specialists	Sarasota, Florida, United States	Recruiting
Moffitt Cancer Center	Tampa, Florida, United States	Recruiting
Winship Cancer Institute, Emory University	Atlanta, Georgia, United States	Recruiting
Northwestern University	Chicago, Illinois, United States	Recruiting
Beth Israel Deaconess Medical Center	Boston, Massachusetts, United States	Recruiting
Dana-Farber Cancer Institute	Boston, Massachusetts, United States	Recruiting
Henry Ford Health Hospital	Detroit, Michigan, United States	Recruiting

+ 14 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05377996